Lakhani, Aliya http://orcid.org/0000-0002-1275-9212
Chen, Ximin
Chen, Laurence C.
Hong, Mihe http://orcid.org/0000-0001-6175-3143
Khericha, Mobina
Chen, Yu http://orcid.org/0009-0001-2693-1693
Chen, Yvonne Y. http://orcid.org/0000-0002-5583-119X
Park, Junyoung O. http://orcid.org/0000-0001-9869-8993
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R35GM143127, T32GM067555)
UC | UCLA | Jonsson Comprehensive Cancer Center
Cancer Research Institute
Alliance for Cancer Gene Therapy
Article History
Received: 9 April 2023
Accepted: 25 March 2024
First Online: 24 April 2024
Competing interests
: X.C. and Y.Y.C. are inventors of a patent whose value may be affected by the publication of this work. Y.Y.C. holds several patent applications in CAR-T cell therapy. Y.Y.C. is a founder of, holds equity in and receives consulting fees from ImmPACT Bio. Y.Y.C. is a member of the scientific advisory board of and holds equity in Catamaran Bio, Notch Therapeutics, Pluto Immunotherapeutics, Prime Medicine, Sonoma Biotherapeutics and Waypoint Bio.